BACKGROUND AND PURPOSE: In the present study we attempt to determine the prevalence of International Classification of Disease-ninth revision, Clinical Modification (ICD-9 CM) coded sleep apnea with cardiovascular and metabolic co-morbidities in Veterans Health Administration (VHA) beneficiaries. PATIENTS AND METHODS: Using VHA administrative databases, we gathered available medical information on more than 4 million veterans using the VHA during the period between 1998 and 2001. We identified database entries for codes indicating sleep apnea using the ninth revision of the Clinical Modification of the International Classification of Diseases (ICD-9 CM); and tabulated demographic data including age, gender, ethnicity, and cardiovascular and metabolic co-morbidities. RESULTS: We found 118,105 unique cases (out of 4,060,504) with sleep apnea ICD-9 CM codes (prevalence of 2.91%). Mean age at diagnosis was 57.6 with more than 38% older than 65 years. Comorbid diagnoses in this group included hypertension (60.1%), obesity (30.5%), diabetes mellitus (32.9%), cardiovascular disease (including MI and angina) (27.6%), heart failure (13.5%), and cerebrovascular accident (including Transient Ischemic Attack (TIA)) (5.7%). CONCLUSIONS: We found a high prevalence of diagnosed sleep apnea among VHA beneficiaries. Additionally, cardiovascular and metabolic conditions were common in these patients.
BACKGROUND AND PURPOSE: In the present study we attempt to determine the prevalence of International Classification of Disease-ninth revision, Clinical Modification (ICD-9 CM) coded sleep apnea with cardiovascular and metabolic co-morbidities in Veterans Health Administration (VHA) beneficiaries. PATIENTS AND METHODS: Using VHA administrative databases, we gathered available medical information on more than 4 million veterans using the VHA during the period between 1998 and 2001. We identified database entries for codes indicating sleep apnea using the ninth revision of the Clinical Modification of the International Classification of Diseases (ICD-9 CM); and tabulated demographic data including age, gender, ethnicity, and cardiovascular and metabolic co-morbidities. RESULTS: We found 118,105 unique cases (out of 4,060,504) with sleep apnea ICD-9 CM codes (prevalence of 2.91%). Mean age at diagnosis was 57.6 with more than 38% older than 65 years. Comorbid diagnoses in this group included hypertension (60.1%), obesity (30.5%), diabetes mellitus (32.9%), cardiovascular disease (including MI and angina) (27.6%), heart failure (13.5%), and cerebrovascular accident (including Transient Ischemic Attack (TIA)) (5.7%). CONCLUSIONS: We found a high prevalence of diagnosed sleep apnea among VHA beneficiaries. Additionally, cardiovascular and metabolic conditions were common in these patients.
Authors: Brittanny M Polanka; Suman Kundu; Kaku A So-Armah; Matthew S Freiberg; Samir K Gupta; Roger J Bedimo; Matthew J Budoff; Adeel A Butt; Chung-Chou H Chang; Stephen S Gottlieb; Vincent C Marconi; Julie A Womack; Jesse C Stewart Journal: J Acquir Immune Defic Syndr Date: 2019-05-01 Impact factor: 3.731
Authors: Scott G Williams; Jacob Collen; Emerson Wickwire; Christopher J Lettieri; Vincent Mysliwiec Journal: Curr Psychiatry Rep Date: 2014-08 Impact factor: 5.285
Authors: Cathy A Alessi; Constance H Fung; Joseph M Dzierzewski; Lavinia Fiorentino; Carl Stepnowsky; Juan C Rodriguez Tapia; Yeonsu Song; Michelle R Zeidler; Karen Josephson; Michael N Mitchell; Stella Jouldjian; Jennifer L Martin Journal: Sleep Date: 2021-04-09 Impact factor: 5.849
Authors: Carol A Janney; Amy M Kilbourne; Anne Germain; Zongshan Lai; Katherine D Hoerster; David E Goodrich; Elizabeth A Klingaman; Lilia Verchinina; Caroline R Richardson Journal: Sleep Date: 2016-01-01 Impact factor: 5.849
Authors: Maple M Fung; Katherine Peters; Susan Redline; Michael G Ziegler; Sonia Ancoli-Israel; Elizabeth Barrett-Connor; Katie L Stone Journal: Hypertension Date: 2011-08-29 Impact factor: 10.190
Authors: Bernardo J Selim; Brian B Koo; Li Qin; Sangchoon Jeon; Christine Won; Nancy S Redeker; Rachel J Lampert; John P Concato; Dawn M Bravata; Jared Ferguson; Kingman Strohl; Adam Bennett; Andrey Zinchuk; Henry K Yaggi Journal: J Clin Sleep Med Date: 2016-06-15 Impact factor: 4.062